Poly-ADP-Ribose Binding Proteins
"Poly-ADP-Ribose Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that contain POLY-ADP RIBOSE BINDING MOTIFS. They include HISTONES and other proteins that function in DNA REPAIR, replication, gene transcription, and APOPTOSIS.
Descriptor ID |
D000075223
|
MeSH Number(s) |
D12.776.157.687 D12.776.660.720
|
Concept/Terms |
Poly-ADP-Ribose Binding Proteins- Poly-ADP-Ribose Binding Proteins
- Binding Proteins, Poly-ADP-Ribose
- Poly ADP Ribose Binding Proteins
- pADPr-Binding Proteins
- pADPr Binding Proteins
|
Below are MeSH descriptors whose meaning is more general than "Poly-ADP-Ribose Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "Poly-ADP-Ribose Binding Proteins".
This graph shows the total number of publications written about "Poly-ADP-Ribose Binding Proteins" by people in this website by year, and whether "Poly-ADP-Ribose Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 2 | 2 |
2003 | 0 | 3 | 3 |
2004 | 0 | 1 | 1 |
2005 | 0 | 6 | 6 |
2006 | 0 | 2 | 2 |
2007 | 0 | 3 | 3 |
2008 | 0 | 3 | 3 |
2009 | 0 | 2 | 2 |
2010 | 0 | 3 | 3 |
2011 | 0 | 4 | 4 |
2012 | 0 | 3 | 3 |
2013 | 0 | 5 | 5 |
2014 | 0 | 1 | 1 |
2015 | 0 | 3 | 3 |
2016 | 0 | 2 | 2 |
2017 | 1 | 3 | 4 |
2018 | 2 | 2 | 4 |
2019 | 1 | 1 | 2 |
2020 | 0 | 1 | 1 |
2021 | 1 | 1 | 2 |
2022 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Poly-ADP-Ribose Binding Proteins" by people in Profiles.
-
De novo variants in genes regulating stress granule assembly associate with neurodevelopmental disorders. Sci Adv. 2022 08 19; 8(33):eabo7112.
-
Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers. JCO Precis Oncol. 2022 02; 6:e2100267.
-
TDRD3 is an antiviral restriction factor that promotes IFN signaling with G3BP1. PLoS Pathog. 2022 01; 18(1):e1010249.
-
Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase III catalytic domain is regulated by phosphorylation of its flexible N-terminus. J Biol Chem. 2021 08; 297(2):100921.
-
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases. Mod Pathol. 2021 06; 34(6):1143-1152.
-
Composition-dependent thermodynamics of intracellular phase separation. Nature. 2020 05; 581(7807):209-214.
-
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology. Semin Oncol. 2019 12; 46(6):397-402.
-
Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency. Cold Spring Harb Mol Case Stud. 2019 10; 5(5).
-
DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency. Am J Hum Genet. 2018 12 06; 103(6):1038-1044.
-
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018 05 15; 9(1):1908.